Stocklytics Platform
Femasys
FEMY49
$1.28arrow_drop_up4.06%$0.05
NASDAQ - As of Apr 4, 4:28 PM EDT Market Closed
Penny Stock
FEMY49

$1.28

arrow_drop_up4.06%

Performance History

no data available for performance history chart

There's no data available for performance history chart

no data available for key stats

There's no data available for key stats

no data available for ratios/profitability stats

There's no data available for ratios/profitability stats

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Predicted: just now

info

Analyzed by 11 Wall Street experts, Femasys's 12-month projections average at $9.54, spanning from a high of $18.00 to a low of $5.00. This signifies an 695.45% shift from the current price of $1.28.

Analyst Ratings

Buy

Buy
4
100.00%
Hold
0
0.00%
Sell
0
0.00%
Ratings from: April

Last updated: just now

Total: 4
info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

Price$788.17
Perf. (24h)arrow_drop_down0.11%-$0.91
Market Cap$708.73B
Price$538.05
Perf. (24h)arrow_drop_down0.45%-$2.44
Market Cap$494.34B
Price$159.39
Perf. (24h)arrow_drop_down0.39%-$0.62
Market Cap$397.30B
Price$199.86
Perf. (24h)arrow_drop_down0.88%-$1.77
Market Cap$356.69B

About Femasys (FEMY)

Femasys Inc. (FEMY) is a medical technology company that specializes in developing and commercializing innovative solutions for women's healthcare. The company focuses on providing non-surgical, minimally invasive products that improve patient outcomes and enhance healthcare provider efficiency. Femasys is committed to addressing unmet needs and delivering high-quality, cost-effective solutions for women's health issues.
The stock price history of Femasys Inc. (FEMY) reflects the company's growth and success in the healthcare industry. Over the years, the stock has shown a steady upward trajectory, indicating investor confidence in the company's products and future prospects. FEMY has consistently outperformed the market, delivering solid returns for its shareholders.
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Ms. Kathy Lee-Sepsick
Headquarters
Suwanee
Employees
34
Exchange
NASDAQ
add Femasys to watchlist

Keep an eye on Femasys

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Femasys's (FEMY) price per share?

The current price per share for Femasys (FEMY) is $1.28. The stock has seen a price change of $0.05 recently, indicating a 4.07% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Femasys (FEMY)?

For Femasys (FEMY), the 52-week high is $2.4, which is 87.5% from the current price. The 52-week low is $0.73, the current price is 74.39% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Femasys (FEMY) a growth stock?

Femasys (FEMY) has shown an average price growth of -1.65% over the past three years. It has received a score of 54 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Femasys as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Femasys (FEMY) stock price performance year to date (YTD)?

As of the latest data, Femasys (FEMY) has a year-to-date price change of 16.36%. Over the past month, the stock has experienced a price change of -16.88%. Over the last three months, the change has been 14.29%. Over the past six months, the figure is 14.8%.
help

Is Femasys (FEMY) a profitable company?

Femasys (FEMY) has a net income of -$14.25M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 64.54% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -922.39% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.07M, although specific revenue growth data is currently not available. The gross profit is $691.9K. Operating income is noted at -$14.51M. Furthermore, the EBITDA is -$17.21M.
help

What is the market capitalization of Femasys (FEMY)?

Femasys (FEMY) has a market capitalization of $33.39M. The average daily trading volume is 0, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level